Summa Biotech Revenue

Biotechnology Research • Amsterdam, North Holland, Netherlands • 1-10 Employees

Summa Biotech revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Key Contact at Summa Biotech

Ralf Zaal

Founder At Summa Biotech Bv

Company overview

Headquarters	Klokkenbergweg 8, Amsterdam, North Holland 1101AS, NL
Phone number	+3187608413
Website	summa-biotech.com
NAICS	541714
Keywords	Regenerative Medicine, Heart Failure, Rna Therapeutics
Founded	2022
Employees	1-10

Summa Biotech Email Formats

Summa Biotech uses 2 email formats. The most common is {first name} (e.g., john@summa-biotech.com), used 57.1% of the time.

Format	Example	Percentage
{first name}	john@summa-biotech.com	57.1%
{first initial}	j@summa-biotech.com	42.9%

About Summa Biotech

Summa Biotech is a medical biotech company that is founded in 2022 and focuses on developing ground-breaking RNA-based medicines that reverse the damage of ischemic heart disease, which is a leading cause of death worldwide. We aim restore damaged heart tissue by eliciting the regeneration of healthy cells and tissues using RNA therapeutics. Summa Biotech’s strategy is to develop game-changing curative therapies for ischemic heart disease by leveraging academic expertise, cutting-edge disease models and fostering a culture of team excellence.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Founder/Owner

Senior

Employees by Department

Summa Biotech has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

Summa Biotech has never raised funding before.

Frequently asked questions

Summa Biotech is located in Amsterdam, North Holland, NL.

You can reach Summa Biotech at +3187608413.

Summa Biotech generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Summa Biotech has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Summa Biotech was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Summa Biotech has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Summa Biotech

Ralf Zaal

Founder At Summa Biotech Bv

4.8

40,000 users